ProfileGDS5678 / 1443682_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 54% 54% 50% 54% 54% 52% 51% 52% 54% 67% 58% 63% 54% 59% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.3840854
GSM967853U87-EV human glioblastoma xenograft - Control 23.3463554
GSM967854U87-EV human glioblastoma xenograft - Control 33.1941350
GSM967855U87-EV human glioblastoma xenograft - Control 43.2801554
GSM967856U87-EV human glioblastoma xenograft - Control 53.2844854
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.3789252
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3153651
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2442552
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.3025154
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 14.0702467
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4888958
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.7559663
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.3414654
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.5418159